002198 Guangdong Jiaying Pharmaceutical
- 6.46
- +0.03+0.47%
Guangdong Jiaying Pharmaceutical News
Guangdong Jiaying Pharmaceutical: Statement and Commitment of Independent Director Candidates for Listed Companies (Li Shanwei)
Guangdong Jiaying Pharmaceutical: Announcement of the resolution of the seventh temporary meeting of the sixth supervisory board.
Guangdong Jiaying Pharmaceutical: Declaration and commitment of the nominated independent director of the listed company (Xu Chi).
Guangdong Jiaying Pharmaceutical: Statement and commitment of independent director nominees of listed companies (Guo Huaping)
Guangdong Jiaying Pharmaceutical: Statement and Undertaking of Independent Director Candidate (Xu Chi) of Listed Companies.
Guangdong Jiaying Pharmaceutical: Statement and Commitment of Independent Director Candidate (Guo Huaping)
Guangdong Jiaying Pharmaceutical: Announcement on the decision of the 19th special meeting of the sixth board of directors.
Guangdong Jiaying Pharmaceutical: Statement and Commitment of Independent Director Candidates of Listed Companies (Li Shanwei)
Guangdong Jiaying Pharmaceutical: 002198 Jiaying Pharmaceutical Investor Relations Management Information 20240510
Guangdong Jiaying Pharmaceutical: 002198 Jiaying Pharmaceutical Investor Relations Management Information 20240508
Guangdong Jiaying Pharmaceutical: Announcement of Board Resolutions
Guangdong Jiaying Pharmaceutical: Independent Director's Annual Debriefing Report
Guangdong Jiaying Pharmaceutical: 2023 Board Work Report
Guangdong Jiaying Pharmaceutical: Announcement on changes in accounting policies
Guangdong Jiaying Pharmaceutical: Independent Director's Annual Debriefing Report
Guangdong Jiaying Pharmaceutical: Independent Director's Annual Debriefing Report
Guangdong Jiaying Pharmaceutical: Announcement of Supervisory Board Resolutions
Guangdong Jiaying Pharmaceutical: Annual special audit report on the expenditure of related parties' funds
Guangdong Jiaying Pharmaceutical: Internal Control Audit Report
Guangdong Jiaying Pharmaceutical: The Board's Special Opinions on Evaluating the Independence of Independent Directors
Analysis
Price Target
No Data
